MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Blog Roll
Lori Smith

A Beer a Day May Not Keep the Cancer Away

NO RATINGS
View Comments: Newest First | Oldest First | Threaded View
More Blogs from...
Lori Smith
Nurse practitioner Lori Smith shares a new study taking place using gut flora in women with ovarian cancer.
The side effect that no one is talking about: sexual pain, explains nurse practitioner Lori Smith.
Nurse practitioner Lori Smith provides an update on the latest HPV vaccine schedule recommended by the CDC.
A new device may help decrease C. diff infection rates explains nurse practitioner Lori Smith.
Nurse practitioner and health writer Lori Smith explains that insurance companies may now dictate genetic counseling before testing.
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
Josephdug on Cancer Patient Fall Prevention
Josephdug on Cancer Patient Fall Prevention
Josephdug on Cancer Patient Fall Prevention
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org